Advertisement
Research Article

F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma

  • Winnie W. Pong,

    Affiliation: Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Jason Walker,

    Affiliation: The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Todd Wylie,

    Affiliation: The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Vincent Magrini,

    Affiliation: The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Jingqin Luo,

    Affiliation: Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Ryan J. Emnett,

    Affiliation: Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Jaebok Choi,

    Affiliation: Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Matthew L. Cooper,

    Affiliation: Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Malachi Griffith,

    Affiliation: The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Obi L. Griffith,

    Affiliation: The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Joshua B. Rubin,

    Affiliation: Department of Pediatrics, Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Gregory N. Fuller,

    Affiliation: Department of Pathology, MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • David Piwnica-Worms,

    Affiliation: BRIGHT Institute and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Xi Feng,

    Affiliation: Department of Stem Cell Biology and Regeneration, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

    X
  • Dolores Hambardzumyan,

    Affiliation: Department of Stem Cell Biology and Regeneration, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

    X
  • John F. DiPersio,

    Affiliation: Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Elaine R. Mardis,

    Affiliation: The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • David H. Gutmann mail

    gutmannd@neuro.wustl.edu

    Affiliation: Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America

    X
  • Published: October 11, 2013
  • DOI: 10.1371/journal.pone.0077571

About the Authors

Winnie W. Pong, Ryan J. Emnett, David H. Gutmann
Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America
Jason Walker, Todd Wylie, Vincent Magrini, Malachi Griffith, Obi L. Griffith, Elaine R. Mardis
The Genome Institute, Washington University School of Medicine, St. Louis, Missouri, United States of America
Jingqin Luo
Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America
Jaebok Choi, Matthew L. Cooper, John F. DiPersio
Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America
Joshua B. Rubin
Department of Pediatrics, Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, Missouri, United States of America
Gregory N. Fuller
Department of Pathology, MD Anderson Cancer Center, Houston, Texas, United States of America
David Piwnica-Worms
BRIGHT Institute and Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, United States of America
Xi Feng, Dolores Hambardzumyan
Department of Stem Cell Biology and Regeneration, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

Corresponding Author

Email: gutmannd@neuro.wustl.edu

Competing Interests

The authors have read the journal's policy and have the following potential conflicts; there are no direct conflicts of interest. Dr. Pong reports grants from the W. M. Keck Foundation during the conduct of the study. Dr. Feng reports personal fees from National Cancer Institute and Cleveland Clinic, and non-financial support from University of Michigan outside the submitted work. Dr. Mardis reports personal fees from Pacific Biosciences Inc and from Illumina Inc, and other from Life Technologies, outside the submitted work. Dr. Gutmann reports grants from National Cancer Institute and from National Institutes of Health during the conduct of the study; personal fees from Biomarin, outside the submitted work; In addition, Dr. Gutmann has Neurofibromatosis type 1 patents. None of these organizations were involved in the study design; collection, analysis and interpretation of data; writing of the paper; and/or decision to submit for publication. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: WWP ERM DHG. Performed the experiments: WWP RJE JC MLC XF. Analyzed the data: WWP JW TW VM JL RJE JC MLC MG OLG. Contributed reagents/materials/analysis tools: VM GNF DH JFD ERM DHG. Wrote the manuscript: WWP DHG. Jointly supervised research: WWP VM ERM DHG. Contributed to experimental design: JW TW VM JC JBR DP-W DH. Contributed to the preparation of the manuscript: WWP JW TW VM MG OLG. Edited and approved the manuscript: DHG WWP TW VM JL RJE JC MLC MG OLG JBR GNF DP-W XF DH JFP ERM.